DETERMINING THE OPTIMAL DOSE OF PHOTOFRIN® IN MINISWINE ATHEROSCLEROTIC PLAQUE
- 1 March 1993
- journal article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 57 (3) , 518-525
- https://doi.org/10.1111/j.1751-1097.1993.tb02329.x
Abstract
The purpose of this study was to determine the lowest dose of Photofrin (P) that would produce a 3:1 or greater ratio between atherosclerotic (AS) and control arterial walls. Aortoiliac AS was created in 24 Yucatan miniswine by a combination of balloon endothelial injury and 2% cholesterol and 15% lard diet for 7 weeks. Arteriography was then performed to demonstrate AS lesions. Following this, swine were given intravenously P in one of the following single dosages: 2.5, 1.0 or 0.5 mg/kg. Twenty-four hours later, swine were sacrificed and aortoiliac and control carotid artery segments removed and photographed with ultraviolet light to differentiate fluorescent from nonfluorescent areas. Arterial specimens were submitted for histologic analysis and chemical extraction for determination of fluorescence using a spectrofluorometer. Tissue concentration (ng/g tissue) of P from AS vessels were: Group I, 130.4 +/- 82.7; Group II, 10.0 +/- 1.2; and Group III, 9.1 +/- 0.6, respectively (P < 0.05). Ratios of P concentration in AS: control vessels were: Group I, 8.1 +/- 13.7; Group II, 1.1 +/- 0.2; and Group III, 0.9 +/- 0.1, respectively (P < 0.05). These results demonstrated that a P dose of 2.5 mg/kg provided at least a 3:1 ratio between AS: control artery wall.Keywords
This publication has 27 references indexed in Scilit:
- Presence of blood significantly decreases transmission of 630 nm laser lightLasers in Surgery and Medicine, 1991
- Detection of experimental atherosclerosis with indium-111 radiolabelled hematoporphyrin derivativeNuclear Medicine Communications, 1989
- Hematoporphyrin uptake in atherosclerotic plaquesNeurosurgery, 1988
- Hematoporphyrin binding to cultured aortic smooth muscle cells from spontaneously atherosclerotic turkeyAtherosclerosis, 1988
- Photodynamic therapy.Journal of Clinical Oncology, 1988
- PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORSPhotochemistry and Photobiology, 1987
- Endogenous porphyrin fluorescence in tumorsLasers in Surgery and Medicine, 1987
- Dose measurements in photodynamic therapy of cancerLasers in Surgery and Medicine, 1987
- Effect of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbitsThe American Journal of Cardiology, 1985
- Arterial endothelial permeability and vascular disease the “trap door” effectExperimental and Molecular Pathology, 1973